Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

28.18
-0.1700-0.60%
Volume:83.68K
Turnover:2.38M
Market Cap:4.48B
PE:-9.28
High:28.76
Open:28.31
Low:28.08
Close:28.35
Loading ...

Optimistic Future Outlook for Ionis Pharmaceuticals Driven by Robust Growth and Strategic Initiatives

TIPRANKS
·
23 Feb

Ionis Pharmaceuticals price target lowered to $60 from $61 at Raymond James

TipRanks
·
21 Feb

Pharma Stock Roundup: EU Nod to MRK's Welireg, IONS' Q4 Results & More

Zacks
·
21 Feb

Ionis Pharmaceuticals Inc : Bernstein Cuts Target Price to $43 From $51

THOMSON REUTERS
·
21 Feb

BRIEF-New Positive Donidalorsen Data To Be Presented At Aaaai/Wao Joint Congress

Reuters
·
20 Feb

New Positive Donidalorsen Data to Be Presented at Aaaai/Wao Joint Congress Highlight Sustained Hae Attack Rate Reduction and Disease Control

THOMSON REUTERS
·
20 Feb

Ionis Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
20 Feb

Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
20 Feb

Barclays Remains a Hold on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
20 Feb

Q4 2024 Ionis Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
20 Feb

Ionis Pharmaceuticals Inc (IONS) Q4 2024 Earnings Call Highlights: Surpassing Revenue ...

GuruFocus.com
·
20 Feb

Optimistic Buy Rating for Ionis Pharmaceuticals Driven by Promising Financial Outlook and Strategic Advancements

TIPRANKS
·
20 Feb

Ionis Pharmaceuticals price target lowered to $38 from $45 at Stifel

TIPRANKS
·
20 Feb

Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales

Benzinga
·
20 Feb

Ionis Pharmaceuticals trading resumes

TIPRANKS
·
19 Feb

Ionis Pharmaceuticals Shares up 1.6% After Q4 Sales Beat

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals trading halted, volatility trading pause

TIPRANKS
·
19 Feb

Stock Track | Ionis Pharmaceuticals Surges 6.42% Pre-Market on Strong Q4 Beat and Bright 2025 Outlook

Stock Track
·
19 Feb

Ionis Pharmaceuticals Shares up 5% Premarket After Q4 Sales Beat

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
19 Feb